Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.05	37.87	33.20
Graham Fair Price	21.56	25.46	20.94
PEG	-51.70	0.20	-0.41
Price/Book	45.78	13.07	8.96
Price/Cash Flow	63.76	-47.29	28.88
Prices/Earnings	-19.64	12.62	15.71
Price/Sales	30.95	3.94	3.01
Price/FCF	63.76	-47.29	28.88
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	25.09	0.32	0.26
Operating Margin	20.72	0.16	0.13
ROA	60.78	0.01	< 0.005
ROE	0.14	0.26	81.41
ROIC	0.03	0.03	-8.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	< 0.005	5530.21
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.17	0.18	3.65
EPS QOQ	-0.38	0.63	66.39
FCF QOQ	-0.37	-1.78	-374.96
Revenue QOQ	< 0.005	-0.02	205.58
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5.52	6.31	14.37
Days Sales Outstanding (DSO)	69.12	87.67	26.84
Inventory Turnover	16.31	14.26	-12.56
Debt/Capitalization	0.89	0.93	4.18
Quick Ratio	1.09	1.30	18.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	11.69	10.55	-9.74
Cash	5.27	4.05	-23.11
Capex	-1.76	-1.38	21.64
Free Cash Flow	3.63	-2.91	-19.65
Revenue	34.82	34.98	0.48
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.19	1.43	20.08
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.58	18.45	4.94
Naive Interpretation	Member

06 - Financial Health · Weak

Rating